drugset / Trial / NCT06917508
A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The primary aim of this study is to assess the effect of EDP-323 on the pharmacokinetics and safety of midazolam, caffeine, and rosuvastatin in healthy adult participants.
Timeline
- Start
- 2025-03-13
- Primary completion
- 2025-06-06
- Completion
- 2025-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | — |
| Subject | EDP-323 | Unknown | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |